Evelyn Partners Investment Management Services’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
VCM
VPM
Evelyn Partners Investment Management Services's MRNA Position: Q1 2026 in Review
Evelyn Partners Investment Management Services held its Moderna (MRNA) position steady in Q1 2026 at 304 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #239.
Evelyn Partners Investment Management Services first reported a position in MRNA in Q4 2024 and has held it in 6 quarters since. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.
- Evelyn Partners Investment Management Services held 304 shares of Moderna worth $15.4K as of Q1 2026.
- Evelyn Partners Investment Management Services left its Moderna share count unchanged in Q1 2026.
- Moderna made up ﹤0.01% of Evelyn Partners Investment Management Services's portfolio in Q1 2026, its #239 holding.
- Evelyn Partners Investment Management Services first reported a position in Moderna in Q4 2024 and has held it in 6 quarters since.
- 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.
Based on Evelyn Partners Investment Management Services's 13F filing for Q1 2026, filed 15 May 2026.